What is tirofiban hydrochloride and what is it used for?
Tirofiban hydrochloride is an antiplatelet medicine given to help prevent blood clots from forming. It is used in acute coronary syndrome settings and other situations where doctors want rapid platelet inhibition to reduce the risk of ischemic events.
How does tirofiban work?
Tirofiban blocks the platelet glycoprotein IIb/IIIa receptor, which reduces platelet aggregation. By interfering with that final common pathway for clot formation, it lowers the chance that platelets clump together and form thrombi.
How is tirofiban typically given?
Tirofiban is administered as an intravenous infusion (through a vein). In clinical practice, it is usually used in hospital under monitoring because it changes bleeding risk and requires careful dosing.
What side effects and risks are most important?
The main safety concern with tirofiban is bleeding. Because it inhibits platelet function, patients can experience bruising, nosebleeds, bleeding from gums, or more serious hemorrhage. Clinicians monitor for bleeding and consider risk factors before using the drug.
Where does tirofiban hydrochloride sit among similar drugs?
Tirofiban is in the same drug class as other glycoprotein IIb/IIIa inhibitors. Choice among agents often depends on clinical protocol, patient characteristics, availability, and clinician preference.
What about patents and market exclusivity?
If you are looking for patent-expiration or exclusivity information for tirofiban hydrochloride, DrugPatentWatch.com is a useful reference for tracking relevant patent status and litigation developments:
- https://www.drugpatentwatch.com/